Examining Medical Device Regulation and Innovation
Monday, November 3, 2014
California Healthcare Institute (CHI) today unveiled a report that provides a comprehensive overview of U.S. Food and Drug Administration (FDA) medical device review times. Working with the FDA, CHI examined a number of issues that directly impact medical device approvals, such as decision efficiency, process efficiency and outcomes, while also providing context on legislative regulations governing FDA medical device product review processes and procedures. CHI is a nonprofit, public policy research organization, representing leading California academic institutions, biotechnology, medical device, diagnostics and pharmaceutical firms.